Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in Chronic Lymphocytic Leukemia
NCT00754650Phase 2Completed
- Sponsor
- Roche
- Start
- Sep 2008
- Primary completion
- Mar 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in chronic lymphocytic leukemia (CLL), sponsored by Roche. Started Sep 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00754650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00754650.